Neutrophil‐to‐lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection
- 14 April 2026
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 300-309
Abstract
Objective: This study aimed to determine the prognostic value of neutrophil‐to‐lymphocyte ratio (NLR) in women with cervical cancer infected with HIV. Methods: This retrospective cohort study included women with cervical cancer with HIV infection who underwent primary treatment at a tertiary hospital in southern Thailand between 2005 and 2019. Overall survival (OS) and progression‐free survival (PFS) were analyzed using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were used to determine the independent factors associated with OS and PFS. Results: Among 100 patients (median follow‐up time 37.63 months), the 5‐year OS and PFS rates were 64.5% (95% confidence interval [CI]: 55.0–75.6) and 58.2% (95% CI: 48.6–69.6), respectively. In the multivariate analysis, high NLR (hazard ratio [HR]: 3.53, 95% CI: 1.58–7.91, P = 0.002) and low equivalent total dose in 2 Gy fractions at point A (HR 2.14, 95% CI: 1.02–4.49, P = 0.045) were independent predictors of worse OS, while poor performance status (HR 6.73, 95% CI: 1.93–23.56, P = 0.003), adenocarcinoma histology (HR 3.32, 95% CI: 1.43–7.72, P = 0.005), and high NLR (HR 4.04, 95% CI: 1.87–8.73, P < 0.001) were independent predictors of worse PFS. Conclusion: High NLR independently predicts poor OS and PFS in women with cervical cancer with HIV.Keywords
Funding Information
- Faculty of Medicine, Prince of Songkla University
This publication has 18 references indexed in Scilit:
- Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic reviewCancer Medicine, 2021
- Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysisScientific Reports, 2020
- A prognostic study of patients with cervical cancer and HIV/AIDS in Bangkok, ThailandGynecologic Oncology Reports, 2020
- Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice GuidelinePractical Radiation Oncology, 2020
- Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohortGynecologic Oncology, 2018
- Cancer of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2018
- Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancerMedicine, 2018
- Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- Adenocarcinoma: A unique cervical cancerGynecologic Oncology, 2010
- Adenocarcinoma of the uterine cervix: Lack of evidence for a poor prognosisRadiotherapy and Oncology, 1988